The 2010 ESC/EACTS guidelines on myocardial revascularisation

Heart

Volumn 97, Issue 6, 2011, Pages 445-446

  Taggart, David P ^a   Boyle, Roger ^b   De Belder, Mark A ^c   Fox, Keith A A ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Department of Health ^*  (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

CORONARY DISEASE; EUROPE; HUMANS; MYOCARDIAL REVASCULARIZATION; PRACTICE GUIDELINES AS TOPIC;

EID: 79952004512     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.216135     Document Type: Editorial

References (10)

1. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;20:2501-55.
2. Fox K, Garcia MA, Ardissino D, et al; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81. (Pubitemid 43998110)
3. Graham I, Atar D, Borch-Johnsen K, et al; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-414.
4. European Society of Cardiology. Writing ESC guidelines. The ESC has issued recommendations for formulating guidelines. http://www.escardio.org/ guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx.
5. Taggart DP. Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 2006;82:1966-75. (Pubitemid 44781367)
6. Bridgewater B, Kinsman R. Sixth National Adult Cardiac Surgical Database Report. Demonstrating Quality. 2008. Henley-on-Thames, UK: Dendrite Clinical Systems, 2009.
7. Taggart DP, Altman DG, Gray AM, et al; on behalf of the ART Investigators. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J 2010;20:2470-81.
8. Serruys PW, Morice MC, Kappetein AP, et al; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
9. Mohr FW. SYNTAX 3VD: Three-Year Outcomes from a Prospective Randomized Trial of Paclitaxel-Eluting Stents Compared to Bypass Graft Surgery in Patients with Triple Vessel Coronary Artery Disease. Washington: TCT, 2010.
10. Serruys PW. SYNTAX Left Main: Three-Year Outcomes from a Prospective Randomized Trial of Paclitaxel-Eluting Stents Compared to Bypass Graft Surgery in Patients with Left Main Coronary Artery Disease. Washington: TCT, 2010.